Fresh Perspectives
Medical and Life Sciences
RPC's Medical / Life Sciences team tracks the critical societal, industrial and legal developments affecting risk management in the medical and life sciences sectors.
Blog
Weighty issues for diet app developers
Topic: Medical and Life Sciences 04.01.2022 Read more
Blog
New guidance on Machine Learning – plenty for humans to learn too
Topic: Medical and Life Sciences 04.11.2021 Read more
Blog
Ho v Adelekun [2021]: Supreme Court decision on QOCS spells bad news for defendants and insurers
Topic: Medical and Life Sciences 18.10.2021 Read more
Blog
Blood Tube Shortage: Testing Times
Topic: Medical and Life Sciences 03.09.2021 Read more
Blog
The latest addition to Kwasi Kwarteng's reading list
Topic: Medical and Life Sciences 24.08.2021 Read more
Blog
The government responds to Cumberlege - What now for product liability risks in the life sciences sector?
Topic: Medical and Life Sciences 26.07.2021 Read more
Blog
Life sciences and the Brexit trade agreement of Christmas Eve 2020
Topic: Medical and Life Sciences 26.03.2021 Read more
Blog
Covid-19 vaccines: an injection of politics
Topic: Medical and Life SciencesA legacy of the pandemic will be greater debate, amongst politicians and the public, about how life sciences products are brought to the market.
07.01.2021 Read more
Blog
The Nocebo Effect: study into statins signals a timely warning
Topic: Medical and Life Sciences 17.11.2020 Read more
Blog
Buyer Beware: NHSX Guidance on Artificial Intelligence
Topic: Medical and Life SciencesNHSX Guide on AI is a useful resource for manufacturers and insurers in mitigating litigation risks
15.10.2020 Read more
